• EE300 Health Care Resource Utilisation (HCRU) and Corresponding Costs of Respiratory Syncytial Virus (RSV) Admissions Before the Age of Two in England

    Dec 1, 2022, 00:00

  • PCR77 Factors to Consider in Deciding on B/Ts Dmards to Manage Inflammatory Arthritis From a Patient Perspective: A Systematic Review

    Dec 1, 2022, 00:00

  • EE470 Zanubrutinib Versus Ibrutinib to Treat Adults With Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL): A Cost Per Responder Model From a Payer Perspective in the United States

    Dec 1, 2022, 00:00

  • SA24 Effects of Navigated rTMS for the Hemiparetic Upper Extremity Motor Function in Stroke Patients – Pilot Study

    Dec 1, 2022, 00:00

  • PCR173 Patient and Carer Involvement (PI) in Real World Data Evidence Generation (RWDEG): Findings From Industry

    Dec 1, 2022, 00:00

  • HTA231 Estimation of Expected Years of Living With Disability in Patients With Non-Small Cell Lung Cancer

    Dec 1, 2022, 00:00

  • HTA240 Indirect Comparisons of Clinical Effectiveness in NICE HTA Submissions: Software Use Trends, 2000-2022

    Dec 1, 2022, 00:00

  • EE232 Evaluate Healthcare Resource Utilization (HCRU) Among Patients With Relapsing Remitting Multiple Sclerosis (RRMS) With Active Disease

    Dec 1, 2022, 00:00

  • MSR12 Validation of Four EQ-5D-5L Crosswalk Prediction Models From Promis-29 in Patients With Cardiovascular Disease

    Dec 1, 2022, 00:00

  • P52 Patient Preferences for Diagnostic Imaging Services Among Underserved and Rural Populations: Blueprint for Value-Based Incentives Incorporating Individual Preference Heterogeneity

    Dec 1, 2022, 00:00

  • EE100 An Approach to Value-Based Pricing for Digital Health Applications in Germany

    Dec 1, 2022, 00:00

  • EE515 Cost Per Responder Analysis of Methotrexate Versus Other Therapies in the Treatment of Moderate to Severe Plaque Psoriasis in Italy

    Dec 1, 2022, 00:00

  • HTA117 A Targeted Literature Review Into Incorporating Environmental Impact of Healthcare Into Health Technology Assessments (HTAS)

    Dec 1, 2022, 00:00

  • HPR47 Comparison of the Characteristics and Costs of Vulnerable Populations Hospital Stays in France Regarding Their Coverage Type Between 2011 and 2021

    Dec 1, 2022, 00:00

  • HTA167 Transition to New Danish HTA Process

    Dec 1, 2022, 00:00

  • HPR174 Social Value Evaluation of Long-Term Care Insurance in Korea: Social Return on Investment Approach (SROI)

    Dec 1, 2022, 00:00

  • RWD70 Electronic Implementation of Patient-Reported Outcomes: Challenges and Potential Solutions

    Dec 1, 2022, 00:00

  • HTA217 Reimbursement of Drugs for Rare Diseases in Canada: Do Treatment Cost and Cost-Effectiveness Ratio Correlate With Epidemiologic Factors?

    Dec 1, 2022, 00:00

  • EE563 Evaluating the Cost-Utility of Intravesical Bacillus Calmette-Guérin Versus Radical Cystectomy in Patients With High-Risk Non-Muscle-Invasive Bladder Cancer in the UK

    Dec 1, 2022, 00:00

  • EE561 Estimation of the Economic Burden of Renal Complications of Diabetes in Algeria

    Dec 1, 2022, 00:00

  • Key Trends in HTA Policy: Present and Future

    Dec 1, 2022, 00:00

  • RWD121 Assessing the Use of Variational Bayes for Large Real-World Data

    Dec 1, 2022, 00:00

  • EPH117 Coinfections in COVID-19 Patients in India: A Systematic Review

    Dec 1, 2022, 00:00

  • EPH40 Polyconsultant Patient: A Dynamic Definition for Users Attending Primary Care Emergency Services

    Dec 1, 2022, 00:00

  • EE254 A Cost-Utility Analysis of Ferric Derisomaltose Versus Ferric Carboxymaltose in Patients With Inflammatory Bowel Disease in Italy

    Dec 1, 2022, 00:00

  • EPH118 Healthcare Systems Sustainability and Resilien Creating an Index

    Dec 1, 2022, 00:00

  • EE246 Real-World Costs and Health Care Resource Utilization (HCRU) Among Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) in the US

    Dec 1, 2022, 00:00

  • P28 Evidence-Informed Deliberative Process for Health Technology Assessment in Spain

    Dec 1, 2022, 00:00

  • EPH42 Long-Term Impacts of Air Pollution on Health-Related Quality of Life Among Older Adults in China

    Dec 1, 2022, 00:00

  • PCR20 Diversity of Patient Support Programs for Severe Asthma Treated with Biologic Therapies – A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EPH167 Proportions of Avoidable GP Visits in Fran Findings From a National Claims Database

    Dec 1, 2022, 00:00

  • HTA223 The Current Status and Challenges of Value Assessment in Prevention and Treatment for Alzheimer’s Disease Dementia in Japan

    Dec 1, 2022, 00:00

  • HTA19 How Are United States ICER’S Evidence Ratings Determined? A Systematic Review of ICER’S Evidence Ratings in Evidence Reports for New Drugs in 2020 and 2021

    Dec 1, 2022, 00:00

  • EPH18 Neovascular Age-Related Macular Degeneration: Prevalence and Treatment With Anti-VEGF From the Perspective of the Italian National Health System

    Dec 1, 2022, 00:00

  • HTA249 Method in the Madness – Acceptance of Indirect Evidence in Joint Clinical Assessments

    Dec 1, 2022, 00:00

  • EE344 A Systematic Review: Model-Based Cost-Effectiveness Analyses (CEAs) of Guideline-Directed Disease-Modifying Medical Therapies (GDMT) for Heart Failure with Reduced Ejection Fraction (HFrEF)

    Dec 1, 2022, 00:00

  • HPR190 Evaluating the Impact of the Entry of IVD-R in the Biopharmaceutical Industry, With a Focus on Evidence Requirements and Time to Launch

    Dec 1, 2022, 00:00

  • HPR91 Disease-Specific Hardship Financing in India: A Pooled Cross-Section Analysis of Inpatient and Outpatient Cases

    Dec 1, 2022, 00:00

  • MSR45 Challenges in Extrapolation When There Are Multiple Health Outcomes

    Dec 1, 2022, 00:00

  • RWD9 Real-World Relative Dose Intensity in Patients With Advanced or Metastatic Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors in Sweden

    Dec 1, 2022, 00:00

  • HPR95 Opportunities and Challenges for Value Added Medicines: Results of a Scoping Research Based on Expert Interviews

    Dec 1, 2022, 00:00

  • MSR52 Target Trial Emulation (TTE) for Real World Data Analyses to Support HTA Decisions

    Dec 1, 2022, 00:00

  • HPR20 Comparative Analysis of Expenditure on Pharmaceuticals in Czechia and Slovakia – How to Understand the OECD Statistics

    Dec 1, 2022, 00:00

  • PCR85 Modifying QALY

    Dec 1, 2022, 00:00

  • MSR9 A Systematic Literature Review of the Economic and Humanistic Burden of Duchenne Muscular Dystrophy

    Dec 1, 2022, 00:00

  • HSD32 Early Access in Fran Reasons for Refusals and Impact on Market Access

    Dec 1, 2022, 00:00

  • HPR177 Digital Affinity Survey of Payers in the Healthcare Industry in Turkiye

    Dec 1, 2022, 00:00

  • PCR289 Building a Practical Strategy and Framework for Diverse and Inclusive Involvement of Patients and Carers in Real World Data Evidence Generation (RWDEG)

    Dec 1, 2022, 00:00

  • EE271 Health State Utility Values Used in Economic Evaluation of Meningococcal Vaccination: A Systematic Review

    Dec 1, 2022, 00:00

  • EE111 Cost-Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Chronic Heart Failure Irrespective of Left-Ventricle Ejection Fraction in the Netherlands

    Dec 1, 2022, 00:00

  • HTA191 Health Technology Assessment in Gree Evaluation of Current Status and Prospects

    Dec 1, 2022, 00:00

  • EE209 Cost-Effectiveness Analysis of Atezolizumab as Adjuvant Treatment in Adult Patients Following Complete Resection and Platinum-Based Chemotherapy with Non-Small Cell Lung Cancer (NSCLC) in Finland

    Dec 1, 2022, 00:00

  • PCR184 Urban/Rural Differences in Preferences for EQ-5D-5L Health States: A Study of a Multi-Ethnic Region in China

    Dec 1, 2022, 00:00

  • HTA39 Estimating the True Cost of Weight-Based Chemotherapy

    Dec 1, 2022, 00:00

  • CO50 Efficacy and Safety of Itolizumab for the Treatment of Coronavirus Disease (COVID-19): A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EE274 Orphan Drug Pricing Comparisons in Low-, Middle- and High-Income Countries

    Dec 1, 2022, 00:00

  • HTA73 Evaluation of NICE Severity Modifiers

    Dec 1, 2022, 00:00

  • EE526 Public Health Impact and Cost-Effectiveness of Recombinant Zoster Vaccine for Vaccinating Immunocompromised Adults Against Herpes Zoster in the United States

    Dec 1, 2022, 00:00

  • EE509 Burden of Disease in Low-Risk Myelodysplastic Syndromes in Spain

    Dec 1, 2022, 00:00

  • P36 Can Real-World Evidence (RWE) Drive European, UK, and US Payer Decisions in the Reassessment of Oncology Therapies?

    Dec 1, 2022, 00:00

  • EE665 Cost-Minimisation Analysis of Oral Semaglutide Versus Dulaglutide in Patients With Type 2 Diabetes Requiring Treatment With a GLP-1 Receptor Agonist

    Dec 1, 2022, 00:00

  • EPH78 In the Crosshairs: Eating and Fluid Consumption Habits of the Students of the International Bachelor Program at the University of Pécs

    Dec 1, 2022, 00:00

  • EE331 Impact of Model Approach on Economic Evaluation of Nivolumab Plus Chemotherapy for Advanced Gastric, Gastro-Oesophageal Junction and Oesophageal Cancer

    Dec 1, 2022, 00:00

  • EE270 Economic Burden of Young Onset Parkinson's Disease: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • PCR72 Effects on Employment for Adults Within the Early Stages of Manifest Huntington's Disease: A Cross-Sectional Analysis Using Enroll-HD

    Dec 1, 2022, 00:00

  • EE281 Freestyle Libre 2 Flash Glucose Monitoring System: Budget Impact and Cost-Utility Analyses in Type 1 Diabetes From the Italian NHS Perspective

    Dec 1, 2022, 00:00

  • SA35 Productivity Loss in Severe Asthma: A Systematic Review

    Dec 1, 2022, 00:00

  • HPR142 The Impact of Cost-Shifting Policies on the Pharmaceutical Sector in Greece During the Financial Crisis

    Dec 1, 2022, 00:00

  • CO94 Tepotinib Compared With Chemoimmunotherapy in First-Line Non-Small Cell Lung Cancer (NSCLC): Matching Adjusted Indirect Comparison (MAIC) of VISION in MET Exon 14 (METex14) Skipping NSCLC and KEYNOTE-189 in Wild-type NSCLC

    Dec 1, 2022, 00:00

  • HTA213 Seven Years of HTA in Singapore: Practices and Key Drivers

    Dec 1, 2022, 00:00

  • MSR93 Assessing Similarity of Studies for Network Meta-Analysis: The Use of Feasibility Assessment and Sensitivity Analyses to Estimate the Efficacy of Tirbanibulin, a New Drug for Actinic Keratosis

    Dec 1, 2022, 00:00

  • EE132 Budget Impact Related to Complications on Pre-Bariatric Surgery Patients in Brazilian Public Healthcare System

    Dec 1, 2022, 00:00

  • MSR91 Automated Tools to Support Screening in Literature Reviews: What's Out There for Reviewers?

    Dec 1, 2022, 00:00

  • EE59 Assessing Economic Cost of Treatment of an Episode of Malaria and Its Effect on the Well-Being of Households in Comé District Health (CDH), South-West Benin

    Dec 1, 2022, 00:00

  • HPR30 Too Ultra-Rare for Care? Orphan Drug Availability for People Living With Ultra-Rare Respiratory Diseases in the Pre, Present and Post Pandemic Worlds

    Dec 1, 2022, 00:00

  • EPH179 The Economic Impact of Diabetic Ketoacidosis (DKA) in People with T1DM at High Risk for DKA: A Structured Literature Review

    Dec 1, 2022, 00:00

  • EE657 Age and Gender Differences in Direct Non-Health Costs for Formal and Informal Assistance, Costs for Productivity Loss Among Italian Behçet Patients

    Dec 1, 2022, 00:00

  • HPR54 Patient Impact of Transferring Hospital-Only Medicines Dispensing to Community Pharmacies: A Longitudinal Prospective Study

    Dec 1, 2022, 00:00

  • EE397 Budget Impact Analysis of Risdiplam for the Treatment of Spinal Muscular Atrophy in Colombia

    Dec 1, 2022, 00:00

  • PCR114 Patient-Voice RWE: Comparative Burden Collected From an Online Social Platform

    Dec 1, 2022, 00:00

  • CO177 Association Between the Sarcomatoid Status and Percentage of Sarcomatoid on the Clinical Outcomes of Localized Renal Cell Carcinoma Post Nephrectomy

    Dec 1, 2022, 00:00

  • EE450 The Burden of Intraoperative Hypotension in Patients Undergoing High-Risk Noncardiac Surgery and the Role of a Machine Learning-Derived Algorithm to Optimize Its Management: What Are We Missing Ignoring Supportive Innovations?

    Dec 1, 2022, 00:00

  • MSR140 Case Study Comparing Anchored vs Unanchored Approaches to Deriving Time-Varying Hazard Ratios Under Violation of the Proportional Hazards Assumption

    Dec 1, 2022, 00:00

  • EPH153 Increased Prevalence of Post-Traumatic Stress Syndrome Among Healthcare Workers During the Coronavirus Epidemic

    Dec 1, 2022, 00:00

  • RWD50 Characteristics of Plaque Psoriasis Patients Initiating Biologics in the Real-World: Survey of Dermatology Practices Across the US and EU5 Countries

    Dec 1, 2022, 00:00

  • EPH209 Metformin 15-Year Consumption Analysis in Selected European Countries

    Dec 1, 2022, 00:00

  • PCR80 Health-Related Quality of Life in Ulcerative Colitis Patients Treated With Tofacitinib in Randomized Controlled Trials: A Systematic Review and Meta-Analysis

    Dec 1, 2022, 00:00

  • EE165 Cost-Effectiveness Analysis of Liposomal Formulation of Daunorubicin and Cytarabine (CPX-351) for the Treatment of Adult Patients With Newly Diagnosed Therapy-Related AML or AML With Myelodysplasia-Related Changes in Greece

    Dec 1, 2022, 00:00

  • EE117 Understanding the Expected Severity Modifiers Across Diseases Following Changes to NICE Methodology

    Dec 1, 2022, 00:00

  • EPH63 Exploring the Potential Public Health Benefits of a Respiratory Syncytial Virus (RSV) Vaccine Candidate (Ad26.RSV.preF/RSV) Among Individuals Aged 65 Years and Older in the UK: A Preliminary Mathematical Modelling Approach

    Dec 1, 2022, 00:00

  • P15 Role of Systemic Therapy for Advanced/Metastatic Gastric Carcinoma in First Line Treatment: A Systematic Review and Network Meta-Analysis

    Dec 1, 2022, 00:00

  • MSR43 The Use of Safety-Engineered Devices in Preventing Needle-Stick Injuries: A Budget Impact Analysis

    Dec 1, 2022, 00:00

  • EE459 Early Intensification of Oral Semaglutide in the UK: A Cost-Effectiveness Analysis Versus Continuing Metformin and SGLT-2 Inhibitor Therapy

    Dec 1, 2022, 00:00

  • EE166 Cost-Effectiveness of the Pneumococcal Conjugate Vaccine 10 Versus 13 on Pneumococcal Disease in Children in Sweden

    Dec 1, 2022, 00:00

  • EE606 Cost-Effectiveness Analysis of a Potential Vaccine to Prevent Colonization by Helicobacter Pylori in the South-European Context

    Dec 1, 2022, 00:00

  • EE575 Cost-Effectiveness of Low-Dose Computed Tomography Screening for Lung Cancer

    Dec 1, 2022, 00:00

  • CO162 Association Between Hypotension and Drug Interaction of Direct-Acting Antiviral Agents in Hepatitis C Virus-Infected Patients: A Multicenter Study in Taiwan

    Dec 1, 2022, 00:00

  • MT13 A Dynamic Budget Impact Analysis of Surgical Treatment for Obesity in Greece

    Dec 1, 2022, 00:00

  • EE440 Cost-Effectiveness Analysis of 4% Fluorouracil for the Treatment of Actinic Keratosis in the Czech Republic

    Dec 1, 2022, 00:00

  • SA13 The Impact of the COVID-19 Pandemic on Collaboration and Innovation in Antiviral Drug Development: A Multi-Stakeholder Systems Dynamics Analysis

    Dec 1, 2022, 00:00

  • PCR122 Health-Related Quality of Life of Patients With Gall Bladder Cancer: A Targeted Review

    Dec 1, 2022, 00:00

  • HTA243 Health Technology Assessment and Reimbursement of Medical Devices in England, France, and Germany

    Dec 1, 2022, 00:00

  • MSR8 Challenges of Network Meta-Analysis for Safety Outcomes: The Analysis of Tirbanibulin Against Common Treatments in Europe for Actinic Keratosis

    Dec 1, 2022, 00:00

  • RWD29 Use of Telemedicine Services and Health Outcomes in Hypertensive Patients in Pre- and Post-COVID-19 Periods in the United States

    Dec 1, 2022, 00:00

  • PCR14 A Literature Review of Methodology Used in In-Trial Interview Studies in Clinical Development

    Dec 1, 2022, 00:00

  • HTA192 Precision Versus Non-Precision Oncology Drug Submissions to the National Centre for Pharmacoeconomics in Ireland

    Dec 1, 2022, 00:00

  • EE601 Age-Related Macular Degeneration: The Actual Burden and the Possible Saving of an Improved Management in Italy

    Dec 1, 2022, 00:00

  • PCR63 Using Patient Preference to Inform Ritlecitinib Dose Selection for Alopecia Areata Treatment

    Dec 1, 2022, 00:00

  • RWD132 Suitability of Nordic Real-World Data to Support EU Regulatory Decision Making

    Dec 1, 2022, 00:00

  • EE600 Cumulative Cardiovascular or Renal Disease (CVRD) Hospital Costs for Type 2 Diabetics Free of CVRD at Baseline: A 5-Year Cohort Study in the SNDS Nationwide Claims Database

    Dec 1, 2022, 00:00

  • Table of Contents

    Dec 1, 2022, 00:00

  • EE562 Cost-Effectiveness and Budget Impact Analyses of Implementing the First Pillar of Patient Blood Management, With Intravenous (IV) Ferric Carboxymaltose (FCM), on the Turkish Healthcare System

    Dec 1, 2022, 00:00

  • MSR56 Measuring HIV Health Management Efficiency Among Health Insurers in Colombia Using Data Envelopment Analysis

    Dec 1, 2022, 00:00

  • PCR228 Developing Treatment Attributes for a Patient Preference Survey in Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • PCR19 SARS-COV-1 Omicron BA.1 Associated Impact on Quality of Life and Medication Adherence of Multiple Myeloma Patients Treated With Thalidomide or Its Analogues Plus Dexamethasone 1JAN-31MAR2022

    Dec 1, 2022, 00:00

  • EE656 A Cost-Utility Analysis of Avacopan for the Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis, a Rare Disease, in Spain

    Dec 1, 2022, 00:00

  • PCR226 Patient and Public Involvement in Research: Reflections on Open Health Collaborations

    Dec 1, 2022, 00:00

  • HSD67 Real-World Effectiveness in Hypertension and Hyperlipidemia Collaborative Management Between Pharmacies and Primary Care in Portugal: A Multicenter Quasi-Experimental Pragmatic Controlled Trial (USFarmácia®)

    Dec 1, 2022, 00:00

  • EE307 Costs of Treating Soft Tissue Sarcomas and Infantile Fibrosarcoma in Pediatric Patients in Turkiye: A Delphi Panel Study

    Dec 1, 2022, 00:00

  • HTA7 Implementation of Comprehensive Criteria for Decision Making Process of Pricing and Reimbursement in Algeria

    Dec 1, 2022, 00:00

  • RWD26 Real World Evidence Studies Presented in ISPOR 2022: A Descriptive Analysis of Research Posters

    Dec 1, 2022, 00:00

  • EE631 Cost Minimization Analysis of the Switch to a New Immunization Schedule With a Hexavalent (DTAP-HBV-HIB-IPV) Vaccine in Algeria

    Dec 1, 2022, 00:00

  • HSD82 Real-World Assessment of Antiplatelet Treatment Therapies for Patients With Acute Coronary Syndrome (ACS) in the United Kingdom

    Dec 1, 2022, 00:00

  • EE142 The Clinical Benefits and Costs of Potential Cervical Cancer Screening Strategies in the Czech Republic

    Dec 1, 2022, 00:00

  • HPR24 Critical Analysis on Time-to-Reimbursement of Rare Disease Drugs: The Italian Case (AIFA Commissions 2018-2022)

    Dec 1, 2022, 00:00

  • PCR99 Exploring Relative Weighting and Ranking of Potential Bolt-on Item for the Eq-5D-5L-Hk by Pairwise Comparison in Hong Kong Context

    Dec 1, 2022, 00:00

  • EE146 Cost-Effectiveness of Axicabtagene Ciloleucel Versus Other CAR T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma in France

    Dec 1, 2022, 00:00

  • PCR136 Patient and Health Care Professional Experiences of Suboptimal Insulin Dosing

    Dec 1, 2022, 00:00

  • HSD58 Country Differences in the Clinical Manifestations and Treatment Patterns of Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Perspective

    Dec 1, 2022, 00:00

  • HSD23 Operational Waste Savings on Health in a Value-Based Patient Drug Safety Program

    Dec 1, 2022, 00:00

  • EE83 Cost-Effectiveness Analysis of an Active Transcutaneous Bone Conduction Implant for Patients With Conductive or Mixed Hearing Loss or Single-Sided Deafness in Turkey

    Dec 1, 2022, 00:00

  • HPR44 Innovation Value Framework - Evidence From EU-4 and UK

    Dec 1, 2022, 00:00

  • EE506 Budget Impact Analysis of Dapagliflozin in the Treatment of Chronic Kidney Disease in Mexico

    Dec 1, 2022, 00:00

  • HPR103 Pricing Negotiations of ASMR IV Drugs in Fran Impact of the Latest LEEM-CEPS Framework Agreement

    Dec 1, 2022, 00:00

  • CO43 The Role of Different Biomarkers in the Prognosis of COVID-19 Infection

    Dec 1, 2022, 00:00

  • PCR241 Measuring Preferences for Stroke Rehabilitation Using a Discrete Choice Experiment

    Dec 1, 2022, 00:00

  • HPR107 Challenges and Opportunities of the German ‘Coverage with Evidence Development’ Scheme for New Medical Devices: A Mixed-Methods Study

    Dec 1, 2022, 00:00

  • EPH53 The Role of Incentives- Parents’ Intention to Vaccinate Their 5- to 11-Year-Old Children with the COVID-19 Vaccine in Israel

    Dec 1, 2022, 00:00

  • EE167 The Socioeconomic Impact of Disability Progression in Multiple Sclerosis: A Retrospective Cohort Study of the German Neurotransdata (NTD) Registry

    Dec 1, 2022, 00:00

  • EE35 Different Types of Innovative Models for Paying for Gene Therapies - Advantages and Possible Limitations

    Dec 1, 2022, 00:00

  • RWD60 Exploring the Burden of COVID-19 on Eating Disorders Spectrum (Types of Eating Disorders) in Pre- and During-COVID-19 Pandemic Using Real-World Data

    Dec 1, 2022, 00:00

  • HTA110 The Value of Real-World Evidence (RWE) in Melanoma in Health Technology Assessment (HTA) Appraisals

    Dec 1, 2022, 00:00

  • P27 Rationing in an Era of Multiple Tight Constraints: Is Cost-Utility Analysis Still Fit for Purpose?

    Dec 1, 2022, 00:00

  • HTA8 The Catalan Health Service, An Example Where Patients Have Full Medicine Appraisal and Decision-Making Representation

    Dec 1, 2022, 00:00

  • Methodological Statistical Research

    Dec 1, 2022, 00:00

  • EE330 Productivity Losses Associated with Spinal Muscular Atrophy (SMA) in Adult Patients in Sweden Not Treated With Disease Modifying Therapies: A Population-Based Study

    Dec 1, 2022, 00:00

  • EE558 Cost-Effectiveness of Direct Transfer of Acute Ischemic Stroke Patients to Angiography Suite

    Dec 1, 2022, 00:00

  • EE559 The Economic Impact of Reducing Bleeding With Emicizumab in Patients With Hemophilia A and Factor VIII Inhibitors – Brazilian Case

    Dec 1, 2022, 00:00

  • MSR53 A Review of Methods for Estimating Individual Treatment Effect From Real World Data for Use in Health Technology Assessment: Separating Hype From Reality

    Dec 1, 2022, 00:00

  • MT14 How Should Clinical Outcomes Factor Into Purchasing Decisions About Macintosh-Style Laryngoscopes?

    Dec 1, 2022, 00:00

  • HPR64 Opportunities and Challenges for Innovative Drugs in China

    Dec 1, 2022, 00:00

  • EE474 Budget Impact Analysis of Perioperative Nutrition in Surgical Oncology Patients

    Dec 1, 2022, 00:00

  • MSR17 Modernizing Pressure Injury Risk Assessment in the ICU in the COVID Era: Ensemble Super-Learning and Explainable AI

    Dec 1, 2022, 00:00

  • EPH122 Healthcare Consumptions in Patient with Early Ageing Disease: Case-Control Study From a National Claims Database

    Dec 1, 2022, 00:00

  • HTA239 The Challenge of Confidential Commercial Arrangements in Health Technology Assessment: How Often Do They Feature in NICE Technology Appraisal Evaluations?

    Dec 1, 2022, 00:00

  • PCR139 Qualitative Approaches Using Global Assessments to Support Meaningful Within-Person Change (MWPC) Estimates for Patient-Reported Outcome (PRO) Questionnaires in Regulated Clinical Trials

    Dec 1, 2022, 00:00

  • P67 Cumulative Effect of Depression on Health Worsening During The COVID-19 Lockdown Among Diabetic Patients in Europe

    Dec 1, 2022, 00:00

  • EE108 Economic Evaluation of the IGRA Screening Test for the Detection of Micobacterium Tuberculosis Infection: An Analysis for the Italian Health System

    Dec 1, 2022, 00:00

  • PCR189 Health-Related Quality of Life in Patients Receiving Oral Anti-Coagulants: A Cross-Sectional Study

    Dec 1, 2022, 00:00

  • HPR192 An Assessment of the Impact of the Three Memorandum Policies on Health Outcomes of the Greek Population

    Dec 1, 2022, 00:00

  • EE196 Updated Recommendations for Budget Impact Scale for HTA System Implementation in Ukraine

    Dec 1, 2022, 00:00

  • HPR83 Unequal Access of Innovative Dermatology Products Across Canada

    Dec 1, 2022, 00:00

  • EE491 Real-World Costs, Health Care Resource Utilization (HCRU), and Outcomes Among Patients With Triple-Class Exposed Relapsed/Refractory Multiple Myeloma (RRMM) in the US

    Dec 1, 2022, 00:00

  • PCR67 A Systematic Literature Review of Health-Related Quality of Life of Patients With Advanced Esophageal Cancer

    Dec 1, 2022, 00:00

  • EE269 Evolution and Implications of the Portuguese HTA Framework on Health Economics in Patients’ Access to Innovation

    Dec 1, 2022, 00:00

  • MSR23 Health Economic Evaluations Alongside New Clinical Trial Designs – Results of an International Expert Panel Workshop

    Dec 1, 2022, 00:00

  • EE22 Average CET Limit: Is It Possible to Introduce a Single CET for the Whole EEA?

    Dec 1, 2022, 00:00

  • EE16 Cost-Effectiveness of Cannabidiol Add-on Therapy Versus Placebo for the Treatment of Seizures in Tuberous Sclerosis Complex

    Dec 1, 2022, 00:00

  • CO124 Indirect Comparison of Efficacy and Safety for Aumolertinib vs Osimertinib in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2022, 00:00

  • MSR59 Replication and Extrapolation From RCTs to Observational Data to Predict Treatment Effects: Why, What, How

    Dec 1, 2022, 00:00

  • EE214 Modelling Cost Determinants for Treating Metastatic Castration-Resistant Prostate Cancer: An Italian National Healthcare System's Perspective Cost Analysis

    Dec 1, 2022, 00:00

  • EE255 Budget Impact Analysis of the Introduction of a Prognostic Prostate Genomic Biomarker Cancer Test in the Management of Localized Prostate Cancer Patients for Greece

    Dec 1, 2022, 00:00

  • HTA51 Challenges and Opportunities of Health Technology Assessment in Older Adult Immunization

    Dec 1, 2022, 00:00

  • HPR184 Uncertainties Around Tumour Agnostic Therapies in Europe: Barriers and Facilitators of Patient Access

    Dec 1, 2022, 00:00

  • HSD86 Contribution of Clinical Pharmacy Services to the Achievement of Diabetes and Hypertension-Related Quality Measures Among Medicare Patients

    Dec 1, 2022, 00:00

  • EE594 The Cost of Care Among Infantile and Child Spinal Muscular Atrophy Patients: RWE from a Large Claims Database

    Dec 1, 2022, 00:00

  • SA58 Real-World Outcomes for the Treatment of Relapsed/Refractory Multiple Myeloma With Daratumumab: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EPH198 Assessing the Validity of Netherlands Linked Routine Healthcare Resource Utilisation Data in the Investigation of Single-Inhaler Triple Therapy Effectiveness (INTREPID Trial)

    Dec 1, 2022, 00:00

  • SA41 Kinesiophobia After Returning to Play in Football

    Dec 1, 2022, 00:00

  • EE360 Health Care Resource Utilization With Asciminib and Bosutinib Among Adults With Chronic Myeloid Leukemia in Chronic Phase Previously Treated With ≥2 Tyrosine Kinase Inhibitors: Week 48 and Week 96 Results From ASCEMBL Trial

    Dec 1, 2022, 00:00

  • RWD63 Comparison of Certified Secure Processing Environments (SPE) – Novel Platforms for Collection, Augmentation, Structuring, Transfer, Management, Analysis, Sharing, Reporting, and Storage of Sensitive Data?

    Dec 1, 2022, 00:00

  • PCR291 Preferences for Key Features of Gonadotropin-Releasing Hormone Analogues Among Women With Endometriosis in the United States

    Dec 1, 2022, 00:00

  • Projecting the Economic Impact of Compensating Living Kidney Donors in the United States: Cost-Benefit Analysis Demonstrates Substantial Patient and Societal Gains

    Dec 1, 2022, 00:00

  • EE113 Discrete Event Simulation in Obesity: A Feasibility Study

    Dec 1, 2022, 00:00

  • EE320 Humanistic and Economic Burden of Advanced Hepatocellular Carcinoma: A Systematic Review

    Dec 1, 2022, 00:00

  • EE55 Comparative Cost-Utility Analysis of Budesonide and the Six Food Elimination Diet (SFED) for the Prophylaxis of Patients With Eosinophilic Esophagitis (EoE) in the Austrian Setting

    Dec 1, 2022, 00:00

  • HSD40 Development of the Patient-Focused Heart Failure Screening Questionnaire to Support a Predictive Heart Failure Algorithm in Patients Implanted With a Cardiac Electronic Device

    Dec 1, 2022, 00:00

  • EPH17 Osteoporosis Screening in Community Pharmacies in Portugal

    Dec 1, 2022, 00:00

  • EE148 Canadian Cost-Effectiveness Analysis of Deferiprone Compared to Deferoxamine and Deferasirox for the Treatment of Iron Overload in Patients With Sickle Cell Disease and Other Anemias

    Dec 1, 2022, 00:00

  • PCR24 The Humanistic and Economic Impact of Fibrodysplasia Ossificans Progressiva on Primary Caregivers: Results From an International Burden of Illness Survey

    Dec 1, 2022, 00:00

  • RWD136 User Profile, Strip Use Habits, and Benefits of the Freestyle Libre System: A Repeated Cross-Sectional Survey of Community Pharmacies in Portugal

    Dec 1, 2022, 00:00

  • HTA262 Cost Effectiveness Analysis of Paclitaxel Micellar for Treatment of First Relapse Platinum Sensitive Ovarian Cancer

    Dec 1, 2022, 00:00

  • HTA185 HTA Indexing in the Purpose-Built INAHTA and CRD HTA Databases

    Dec 1, 2022, 00:00

  • HTA98 Distribution of the Positive Added Medical Benefit According to the Early Access Status and the Potential Public Health Interest– Analysis of the French HTA Body Opinions (HAS Transparency Committee)

    Dec 1, 2022, 00:00

  • CO53 Real-World Clinical Outcomes and Efficiency of a New Steerable Sheath Technology for Radio-Frequency Ablation in Chinese Patients with Atrial Fibrillation

    Dec 1, 2022, 00:00

  • HSD34 The Development and Validation of a Novel Discrete Simulation Tool for Modeling the Operational Efficiency of Inpatient Electrophysiology Services

    Dec 1, 2022, 00:00

  • CO132 Focuses on the Prevalence and Impact of Metabolic Syndrome on the Outcome of Patients With Acute Coronary Syndrome in Iraq and Hungary

    Dec 1, 2022, 00:00

  • CO86 Clinical Outcomes of Diabetic Macular Edema Patients Treated With Faricimab and Aflibercept: A Subcohort Analysis of 20/50 or Worse Visual Acuity Across Faricimab Phase 3 Clinical Trials

    Dec 1, 2022, 00:00

  • HTA255 Recommendations on the Use of Artificial Intelligence and Machine Learning in Systematic Literature Reviews Submitted as Part of the Evidence Package in Health Technology Assessment

    Dec 1, 2022, 00:00

  • CO21 Validation of Crossover Adjustment Outcomes in a Randomized Clinical Trial (RCT) Using Real-World Evidence (RWE) in Non-Small Cell Lung Cancer (NSCLC)

    Dec 1, 2022, 00:00

  • HTA141 Does NICE’s New Severity Modifier Capture the Value of Treatments for Long-Term Progressive Diseases? A Retrospective Analysis of Past Appraisals in Multiple Sclerosis

    Dec 1, 2022, 00:00

  • PCR158 Patient Reported Outcomes (PRO) From Ongoing Phase 2 Registrational Trial of Repotrectinib in Patients With ROS1-Positive Advanced or Metastatic Non-Small Cell Lung Cancer (TRIDENT-1)

    Dec 1, 2022, 00:00

  • CO104 Real-World Impact of a Prescription Digital Therapeutic on Retention in Treatment and Relapse Indicators in Patients With Opioid Use Disorder

    Dec 1, 2022, 00:00

  • EE262 An Economic Evaluation and Return on Investment of the Community Benefit of the Australian Pregnancy Register of Anti-Seizure Medications

    Dec 1, 2022, 00:00

  • HSD26 Real-World Patterns of Care and Outcomes Among Advanced Cervical Cancer Patients in England: Retrospective Analysis of the NCRAS Datasets, 2012-2019

    Dec 1, 2022, 00:00

  • CO108 Project Ideate: Designing a Robust Methodology for an Experimental, Retrospective Outcome-Based Agreement in a Breast Cancer Treatment

    Dec 1, 2022, 00:00

  • HPR39 Access to Orphan Drugs in Hungary

    Dec 1, 2022, 00:00

  • RWD66 Application of the Target Trial Framework for Estimating Comparative Effectiveness Using Real-World Data - A Systematic Review

    Dec 1, 2022, 00:00

  • EE356 Budget Impact of Extracorporeal Photopheresis for Treatment of Chronic Lung Allograft Dysfunction Following Lung Transplantation in Switzerland – Results of a Single-Center Retrospective Chart Review

    Dec 1, 2022, 00:00

  • HTA64 A Retrospective Review of NICE Appraisals From 2017-2022 to Investigate the Impact of the New Severity Modifier on Cost-Effectiveness Thresholds Across Multiple Therapy Areas

    Dec 1, 2022, 00:00

  • EE366 Healthcare Resource Consumption and Related Costs in Patients Under Antiretroviral Therapies: Findings From Real-World Data in Italy

    Dec 1, 2022, 00:00

  • RWD127 Disparity in Health Care Cost and Resource Utilization in Children With Autism: A Demographic Evaluation

    Dec 1, 2022, 00:00

  • EE50 A Cost-Consequence Model of Using the 21-Gene Breast Recurrence Score Assay to Identify Patients With Early-Stage Node-Positive Breast Cancer Who Benefit From Adjuvant Chemotherapy in the Netherlands

    Dec 1, 2022, 00:00

  • EE225 What Is the Economic Impact of Delaying Kidney Replacement Therapy Through Ketoanalogue-Supplemented Low Protein Diet in Advanced Chronic Kidney Disease?

    Dec 1, 2022, 00:00

  • EE114 Cost-Utility Analysis of Lung Cancer Screening Combined With Cardiovascular Disease and Chronic Obstructive Pulmonary Disease Screening

    Dec 1, 2022, 00:00

  • EE235 Cost Analysis of Enzyme Replacement Therapy Domicile Infusion in the Fabry and Gaucher Syndromes

    Dec 1, 2022, 00:00

  • EE636 Cost of Follow-Up After a Peripheral Arterial Event in Patients With Atherosclerotic Cardiovascular Disease in Spain: Results From the Reality Study

    Dec 1, 2022, 00:00

  • EE21 Costs of Hemophilia in Ukraine

    Dec 1, 2022, 00:00

  • PCR244 Burden of Myelodysplastic Syndromes Part I: Systematic Literature Review of Epidemiologic and Humanistic Burden

    Dec 1, 2022, 00:00

  • EE3 Cost-Utility Analysis of Xelox Plus Bevacizumab Versus Xelox for Metastatic Colorectal Cancer Treatment in Thailand

    Dec 1, 2022, 00:00

  • PCR48 Meaningful Change Is a Perception, Not Only a Number: A Review of Qualitative Interviews Exploring Meaningful Changes in Symptoms

    Dec 1, 2022, 00:00

  • SA55 Literature Review and Meta Analysis of Alternative Autologous Vein in Below Knee Lower Limb Surgical Bypass in Patients With Critical Limb Ischemia Pad

    Dec 1, 2022, 00:00

  • EE629 Methodological Concerns in the Medico-Economic Modeling of Adjuvant Management

    Dec 1, 2022, 00:00

  • HTA86 Health Technology Assessment in Hospitals: A Systematic Review on Methods and Practices

    Dec 1, 2022, 00:00

  • EE553 Hospitalisation and Healthcare Costs in Adults with Systemic Lupus Erythematosus in Sweden: A Real-World Observational Cohort Study

    Dec 1, 2022, 00:00

  • EE333 Evaluating the Long-Term Clinical, Societal, and Economic Outcomes of Ofatumumab vs Teriflunomide/Interferon Β-1A and the Impact of Early vs Delayed Ofatumumab Initiation in Relapsing Multiple Sclerosis Patients in Greece

    Dec 1, 2022, 00:00

  • PCR70 Avalglucosidase Alfa (AVA) Improves Symptoms and Functioning in Late-Onset Pompe Disease (LOPD) Patients vs Alglucosidase Alfa (ALG): Post-Hoc Analyses of Patient-Reported Outcomes (PROs) From COMET Trial

    Dec 1, 2022, 00:00

  • RWD11 Effectiveness Analysis of CPOE Implementation in Preventing Duplicate Medication: An Evidence From a Single Medical Center in Taiwan

    Dec 1, 2022, 00:00

  • MSR33 Application and Feasibility of Indirect Treatment Comparison of Switch Maintenance and Non-Maintenance Oncology Regimens to Inform HTA Decision-Making

    Dec 1, 2022, 00:00

  • EE362 Evaluating the Cost-Effectiveness of Refluxstop as a Treatment for Refractory Gastroesophageal Reflux Disease (GORD)

    Dec 1, 2022, 00:00

  • EPH159 Creating an Online Patient Education Program for Female Population Who Are Over 50 Years Old

    Dec 1, 2022, 00:00

  • PCR287 The Social Burden of the Caregivers of Alzheimer's Disease Patients in Egypt

    Dec 1, 2022, 00:00

  • HTA263 Evaluation of the UK Innovative Licensing and Access Pathway

    Dec 1, 2022, 00:00

  • SA72 Comparing EQ-5D-5L, Propr, Sf-6D and TTO Utilities in Patients With Chronic Skin Diseases

    Dec 1, 2022, 00:00

  • EE107 Ponesimod Indicated for Patients With Active Relapsing Forms of Multiple Sclerosis: A Budget Impact Analysis From the Italian National and Regional Health Care Service Perspective

    Dec 1, 2022, 00:00

  • EE187 Healthcare Resource Utilization in Non-Cystic Fibrosis Bronchiectasis (NCFB) Patients With Commercial Insurance Coverage in the US

    Dec 1, 2022, 00:00

  • HTA127 What Does the NICE Severity Modifier Mean in Reality? Has Cost Neutrality Restricted It Too Much?

    Dec 1, 2022, 00:00

  • RWD53 Recurrence of Major Adverse Cardiovascular Events (MACE) in Patients Who Had a Prior Myocardial Infarction (MI): An Analysis Based on German Claims Data

    Dec 1, 2022, 00:00

  • EE180 Budget Impact Model of Feiba in the Management of Hemophilia Patients With Inhibitors in the Egyptian Public Healthcare System

    Dec 1, 2022, 00:00

  • HTA245 NICE Immuno-Oncology Appraisals: Comparison of Progression-Free Survival and Overall Survival Analysis Methods and Critique

    Dec 1, 2022, 00:00

  • P68 Investing in the Prevention of Infectious Disease Outbreaks: Fiscal Health Modelling for Assessing the Public Investment Case

    Dec 1, 2022, 00:00

  • EPH71 Factors Associating With the Severity of Soccer Injury Among Men and Women Professional Teams

    Dec 1, 2022, 00:00

  • EE639 Health Care Resource Utilization and Costs Among Persons With a Permanent or Temporary Stoma: A Swedish Register Study

    Dec 1, 2022, 00:00

  • Another Step Toward Hepatitis C Elimination: An Economic Evaluation of an Irish National Birth Cohort Testing Program

    Dec 1, 2022, 00:00

  • MT26 A Literature Review on Health Economic Evaluation of Pipeline Embolization Device (PED) in Treating Intracranial Aneurysms

    Dec 1, 2022, 00:00

  • SA7 Reduced Health Care Resource Utilisation and Costs Following a Switch From Multiple-Inhaler to Once-Daily Single-Inhaler Triple Therapy in COPD Patients in a Real-World Primary Care Setting in England

    Dec 1, 2022, 00:00

  • RWD160 Racial Disparity in the Treatment of Psoriasis in the US

    Dec 1, 2022, 00:00

  • SA77 Considerations for Patient Identification and Enrolment for Retrospective Studies for the Collection of Long-Term Follow-up Data

    Dec 1, 2022, 00:00

  • HSD100 A Multidisciplinary and Pharmacological Approach to the Treatment of Overweight and Obesity in a Health Maintenance Organization (HMO) in Brazil

    Dec 1, 2022, 00:00

  • HSD41 Development of 'Quality of Care for Patients With Advanced Illnesses (QCPAI)' Instrument for Measuring the Quality of End-of-Life Care From Patients’ Perspective

    Dec 1, 2022, 00:00

  • CO19 Adjunctive Albumin Infusion During Large-Volume Paracentesis May Improve Days to Next Hospital Readmission in Cirrhotic Patients

    Dec 1, 2022, 00:00

  • HPR23 A Comparative Analysis of Biosimilar Competition in European Markets of TNF-Alpha Inhibitors

    Dec 1, 2022, 00:00

  • EE430 Cost-Effectiveness of Faricimab in Patients With Diabetic Macular Edema in Canada

    Dec 1, 2022, 00:00

  • EE537 Cost-Effectiveness of Cemiplimab in Patients With Advanced Basal Cell Carcinoma (aBCC) Who Progressed on or Are Intolerant to a Hedgehog Inhibitor (HHI) in Italy

    Dec 1, 2022, 00:00

  • HTA89 Androgen Receptor Inhibitors for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer

    Dec 1, 2022, 00:00

  • HTA50 The Architecture of Clinical Prediction Model Research: A Phased Approach

    Dec 1, 2022, 00:00

  • HTA105 Scope, Feasibility and Challenges of Valuing Disability in Cost-Effectiveness Analyses Submitted to the French National Authority for Health (HAS)

    Dec 1, 2022, 00:00

  • CO33 A Systematic Literature Review (SLR) of Comparative Efficacy Measures in Randomized Controlled Trials (RCTS) of Adjuvant Treatment in Localized Renal Cell Carcinoma (RCC)

    Dec 1, 2022, 00:00

  • CO65 Clinical and Economic Burden Among Patients With Prurigo Nodularis Compared to a Benchmark in Germany: A Real-World-Evidence Claims Data Study

    Dec 1, 2022, 00:00

  • HTA83 Role of Quality of Life in Health Technology Assessment Agency Final Recommendations: Insights and Lessons From Review of NICE Technology Assessment Reports (2019-2022)

    Dec 1, 2022, 00:00

  • MSR50 Comparing Survival Extrapolation Outcomes Using Different Network Meta-Analyses (NMA) Methods: An Application in Patients With Metastatic Renal Cell Carcinoma (MRCC) Treated With Immunotherapy (IO) Based Combinations

    Dec 1, 2022, 00:00

  • Award Winners

    Dec 1, 2022, 00:00

  • EE90 Are There Specificities for Assessing Quality of Life and Utilities in Rare Diseases for Economic Evaluation in Fran A Case Study of Published CEESP Opinions

    Dec 1, 2022, 00:00

  • EE676 Impact of Using Innovative Antineoplastic Drugs on Cancer Mortality in Russia

    Dec 1, 2022, 00:00

  • Analyzing the Pain/Discomfort and Anxiety/Depression Composite Domains and the Meaning of Discomfort in the EQ-5D: A Mixed-Methods Study

    Dec 1, 2022, 00:00

  • EE268 Per-Member Per-Month (PMPM) Expenditure Value in Oncology: Updating a Focused Literature Review

    Dec 1, 2022, 00:00

  • HTA198 The Influence of the Claimed Benefit Versus the Given Benefit on the Negotiated Rebate During the German Health Technology Assessment

    Dec 1, 2022, 00:00

  • MSR80 Impact of Donor Ferritin Testing on Iron Deficiency Prevention and Blood Availability in Fran A Cohort Simulation Study

    Dec 1, 2022, 00:00

  • EPH25 Premature Mortality From Ischaemic Heart Disease Among Women in Hungary by District

    Dec 1, 2022, 00:00

  • RWD98 Variation in COVID-19 Length of Stay Due to Social Factors in the US – Estimation Using Integration of CDC/ATSDR's Social Vulnerability Index (SVI) and Healthcare Claims Data

    Dec 1, 2022, 00:00

  • CO3 Sensitivity to Change of the Oxford Participation and Activities Questionnaire in People With Parkinson’s

    Dec 1, 2022, 00:00

  • EE205 Cost-Effectiveness of Adherence Intervention for Tuberculosis Treatments in South Korea Using Discrete Event Simulation Model

    Dec 1, 2022, 00:00

  • HTA9 The Benefits That a Novel Antimicrobial Provides When Viewed From an Insurance Value Perspective

    Dec 1, 2022, 00:00

  • EE534 Economic Evaluations of HIV-1 Disease in South Africa – A Targeted Literature Review

    Dec 1, 2022, 00:00

  • PCR229 Two Simple Methods for Daily Measuring Compliance With Oral Nutritional Supplements in the Community: Electronic Self-Report Method Versus Image-Based Method

    Dec 1, 2022, 00:00

  • MSR115 Comparison of Statistical Models to Address Ceiling Effect in Utility Scores: A Simulation Study

    Dec 1, 2022, 00:00

  • HPR33 Price Erosion for Haemato-Oncology Drugs in European Markets

    Dec 1, 2022, 00:00

  • HTA120 National Health Technology Assessment in Turkey After a Decade: Are Key Principles Followed?

    Dec 1, 2022, 00:00

  • EE392 Cost-Effectiveness Analysis of Atrial Fibrillation Screening for a 50–65-Year-Old Population With Elevated Stroke Risk

    Dec 1, 2022, 00:00

  • CO101 Burden of Post-Stroke Spasticity: A Real-World Data Analysis in Italy

    Dec 1, 2022, 00:00

  • EPH13 Modelling the Impact on Lung Cancer Life Years of Universal Screening for Lung Cancer Amongst Defined High-Risk Populations in Greece

    Dec 1, 2022, 00:00

  • EE429 Cost-Effectiveness and Budget Impact Analyses of Enzalutamide for the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer in Mexico

    Dec 1, 2022, 00:00

  • PCR1 Comparison of Infant’s CRY/Fuss Report Between Parental Perception and Recording Analysis, and Its Potential Implications on Parental Mental Health

    Dec 1, 2022, 00:00

  • PCR161 Being Active Is Not Enough – Combination of Physical Activity, Sedentary Behaviour and Sleep Characteristic Shows More Positive Effect on Infertility Related Quality of Life in Women Undergoing Art

    Dec 1, 2022, 00:00

  • HPR35 Are the Sales Forecast for Medical Devices Accurate? A Retrospective Analysis in France (2018-2021)

    Dec 1, 2022, 00:00

  • EE26 Costs of Illness of Atypical Hemolytic Uremic Syndrome (aHUS)

    Dec 1, 2022, 00:00

  • SA45 Practical Considerations for Developing PICO Statements for Humanistic Burden Reviews: How to Get It Right

    Dec 1, 2022, 00:00

  • SA63 Communicating Complex Methodology Via Infographics: A MAIC Case Study

    Dec 1, 2022, 00:00

  • CO66 Survival of Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib in France During 2009-2018: Potentialities and Limitations of Model Adjustment in the SNDS French Hospital and Claim Database

    Dec 1, 2022, 00:00

  • PCR6 Real-World Outcomes Among Episodic Migraine Patients with Migraine Preventive Medications in China: Results From the Chinese Adelphi Disease Specific Programme

    Dec 1, 2022, 00:00

  • EE259 US Reference Pricing Impact on Transparency, Pricing, and Access in the EU4 Final

    Dec 1, 2022, 00:00

  • EE610 Economic Investment for Saving a Year of Life Following the Israeli Government's Actions in the First Year of the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • HTA45 Uncertainty Regarding the Long-Term Effectiveness of New Therapies in Health Technology Assessment

    Dec 1, 2022, 00:00

  • EE411 Cost-Utility of Nabiximols for the Management of Spasticity Due to Multiple Sclerosis in Switzerland

    Dec 1, 2022, 00:00

  • HTA69 Delay of Innovative Oncology Treatments - Case From Bulgaria

    Dec 1, 2022, 00:00

  • HSD21 Hormone Receptor-Positive (HR+)/Human Epidermal Growth Factor Receptor 2-Negative (HER2-) Advanced/Metastatic Breast Cancer (ABC): Testing Patterns, Prescribing Behavior, and Treatment Option Perceptions Among U.S. Oncologists

    Dec 1, 2022, 00:00

  • EPH74 Mortality From Ischaemic Heart Disease Among Women in Hungary by County

    Dec 1, 2022, 00:00

  • CO62 Prophylaxis Treatment for Patients With Hemophilia A Without Inhibitors: Experience Monitoring Survey on the Use of Damoctocog Alfa Pegol

    Dec 1, 2022, 00:00

  • HTA162 Assessing Literature Reviews in NICE Single and Multiple Technology Appraisals

    Dec 1, 2022, 00:00

  • PCR223 Functional Class and Health-Related Quality of Life in Patients With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease: Findings From a Real-World Study in the US

    Dec 1, 2022, 00:00

  • EE655 Potential Solutions for the Cost-Effectiveness Paradox of Improving Carer Quality-of-Life in Terminal Conditions

    Dec 1, 2022, 00:00

  • MSR81 Alternative Approaches to the Analysis of Utility Data: Atopic Dermatitis

    Dec 1, 2022, 00:00

  • RWD147 Demonstrating the Application of Real-World Evidence for Health Technology Assessment Using a Federated Data Network

    Dec 1, 2022, 00:00

  • PCR46 Assessing the Mental Health of Secondary School Students in the Light of COVID-19

    Dec 1, 2022, 00:00

  • EE442 Care Costs of Non-Small Cell Lung Cancer, Colorectal Cancer, and Thyroid Cancer in Turkiye: A Delphi Panel Study

    Dec 1, 2022, 00:00

  • CO42 Efficacy and Safety of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Treatment of Anaemia of Chronic Kidney Disease: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • CO82 The Assessment of Surrogate Endpoints and Their Impact on HTA Recommendations

    Dec 1, 2022, 00:00

  • HTA85 Possible Impact of Orphan Threshold Reduction to 20 Million Euro in the Framework of Early Benefit Assessment and Reimbursement Price in Germany

    Dec 1, 2022, 00:00

  • EE323 Cost-Utility Analysis of Polygenic Risk Score in the Prevention of Type 2 Diabetes – An Object-Oriented Individual-Level Model With Probabilistic Sensitivity Analysis

    Dec 1, 2022, 00:00

  • HPR141 Modelling the Impact of Pricing Exceptions and Protections on Pharmaceutical Expenditure in Greece

    Dec 1, 2022, 00:00

  • SA80 Data Extraction Templates in Systematic Literature Reviews: How Systematic Are We?

    Dec 1, 2022, 00:00

  • PCR273 Examining the Quality of Life Among Women With Cervical Cancer

    Dec 1, 2022, 00:00

  • HPR75 An Analysis of Special Pricing Arrangements (SPAS) Between 2013 and 2021 in Australia

    Dec 1, 2022, 00:00

  • EPH156 Treatment Patterns and Characteristics of People With Newly Diagnosed Major Depressive Disorder Across the Komodo Claims Database 2018-2020

    Dec 1, 2022, 00:00

  • EPH165 Inequalities in Health Care Attention of Severely Malnourished Children in Remote and Conflicts Zones

    Dec 1, 2022, 00:00

  • A Comparison of Seven Oncology External Control Arm Case Studies: Critiques From Regulatory and Health Technology Assessment Agencies

    Dec 1, 2022, 00:00

  • HSD103 Evolution 2019-2020 of Immune Checkpoint Inhibitors (ICI) Administration in Hospitalization at Home (HAH) for Cancer Patients in Fran Descriptive Analysis From the French Public Health Insurance Database (PMSI)

    Dec 1, 2022, 00:00

  • EE201 Survival Analysis Methods Used in Immuno-Oncology NICE Appraisals

    Dec 1, 2022, 00:00

  • PCR92 Treatment Preference of Moderate or Severe Hemophilia a Patients in Taiwan

    Dec 1, 2022, 00:00

  • EE598 Heterogeneity in Cost-Effectiveness of SGLT2IS Versus DPP4IS According to Baseline Characteristics: A Model-Based Analysis

    Dec 1, 2022, 00:00

  • HTA156 Analysis of the Early Access Reform and Trends Observed in the Evaluation by the HAS

    Dec 1, 2022, 00:00

  • HSD105 Cost Savings Benefits of Operational Waste Minimization in a Care Program by Cohorts of Babies on Treatment With Palivizumab

    Dec 1, 2022, 00:00

  • EPH60 Social and Geographical Inequalities in the Choice of Foot Therapy as Preventive Care of Diabetic Foot Ulcers: A Nationwide Registry Study on Danish Diabetes Patients

    Dec 1, 2022, 00:00

  • PCR171 Considerations for Successful Implementation of Patient-Reported Outcomes in Real-World Evidence Generation: Interviews With Patients and Stakeholders

    Dec 1, 2022, 00:00

  • HPR116 The Impact of Policy Measures to Increase the Uptake of Biosimilar Medicines in Belgium: A Nationwide Interrupted Time Series Analysis

    Dec 1, 2022, 00:00

  • MT33 Value Scorecard - What Matters the Most? A Tool to Iteratively Improve and Successfully Implement Remote Patient Monitoring Service After Cardiothoracic Surgery

    Dec 1, 2022, 00:00

  • EPH14 Prevalence of Depression in Japan and the US Populations Before and During the COVID-19 Pandemic: A Retrospective Observational Study Using Real-World Data

    Dec 1, 2022, 00:00

  • CO153 Mind-Body Modalities for Healthcare Workers in the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • EE140 The Opportunity Cost of Managing Toric IOL Rotation Cases for a Private Cataract Surgery Centre in India: A Decision-Analytic Model Comparing Three Toric IOLs

    Dec 1, 2022, 00:00

  • PCR141 Patient and Caregiver Perceptions Around the Treatment and Quality of Life Impact of Colorectal Cancer: A Social Media Listening Study

    Dec 1, 2022, 00:00

  • MSR74 Can Artificial Intelligence (AI) Replace a Human Reviewer in Systematic Literature Review (SLR)? Validation of the LIVESTARTTM Tool

    Dec 1, 2022, 00:00

  • RWD165 Impact of Armodafinil and Modafinil on Shift Work and Associated Metabolic Disorders

    Dec 1, 2022, 00:00

  • EE613 Burden of Hospitalization, Costs and Co-Morbidities in Medicare Patients With Chronic Graft Versus Host Disease: Analysis of National In-Patient Hospital Database

    Dec 1, 2022, 00:00

  • EE125 The Association Between Body Weight During Late Adolescence and Direct Medical Costs Further in Life

    Dec 1, 2022, 00:00

  • RWD1 Factors Affecting Korean Medicine Health Care Use of Functional Dyspepsia in Korea: Analysis of Korea Health Panel Survey 2017

    Dec 1, 2022, 00:00

  • MSR40 A Comparison of the Performance of a Range of Trial-Level Surrogacy Methods

    Dec 1, 2022, 00:00

  • PCR79 Differences in the Health-Related Quality of Life Between Diabetic Patients With and Those Without Comorbidities in South Korea

    Dec 1, 2022, 00:00

  • HPR87 A Review and Analysis of Medicines Following the Innovative Licensing and Access Pathway (ILAP) in the UK: Does the Pathway Lead to Faster Regulatory Approval and HTA Recommendation?

    Dec 1, 2022, 00:00

  • PCR49 Patient Reported Outcomes in Randomized Controlled Trials of Nervous System and Mental Health Disorders: Current Status in India

    Dec 1, 2022, 00:00

  • EE497 Healthcare Resource Utilization and Costs by Cardiovascular Risk Level: Results From the Latino Study

    Dec 1, 2022, 00:00

  • EE145 Cost-Effectiveness Analysis of the Novel Powered Circular Stapler in Colorectal Anastomosis Surgery

    Dec 1, 2022, 00:00

  • EPH130 Assessment of Pattern of Poisoning Cases in Atertiary Care Hospital

    Dec 1, 2022, 00:00

  • SA16 Enhancing Clinical Trial Diversity and Representation Through Data-Adaptive Targeted Learning: A Tale of Lurking Berkson Bias

    Dec 1, 2022, 00:00

  • EE339 Budget Impact Analysis of Insulin Glargine-300U/Ml (GLA-300) for Treatment of T1DM and T2DM in Algerian Setting

    Dec 1, 2022, 00:00

  • PCR165 Patient Reported Outcomes Measures for Patients With Rheumatoid Arthritis: Patterns of Use Among Spanish Rheumatologists and Barriers for Their Implementation in Routine Care

    Dec 1, 2022, 00:00

  • HPR72 Regional Heterogeneity of the Design and Outcomes of Drug Tendering in Italy

    Dec 1, 2022, 00:00

  • EE579 Economic and Humanistic Evidence in Early-Stage Hepatocellular Carcinoma (HCC) Post Liver Resection or Ablation – A Systematic Literature Review (SLR)

    Dec 1, 2022, 00:00

  • PCR18 An Exploratory Retrospective Social Listening Study to Identify Patient Experiences Associated With Cutaneous Lupus Erythematosus (CLE)

    Dec 1, 2022, 00:00

  • EE499 Challenges of Health Economic Evaluations Alongside Innovative Clinical Trial Designs in Precision Oncology – Results of a Literature Review

    Dec 1, 2022, 00:00

  • HTA210 The Use of Surrogate Endpoints in Health Technology Assessments (HTAs) for Chronic Cancers

    Dec 1, 2022, 00:00

  • HPR148 The Impact of Patient Access Schemes on the Access of Innovative Oncology Medicines in Asia-Pacific Region: A Targeted Review

    Dec 1, 2022, 00:00

  • MSR30 Linguistic and Psychometric Validation of the “Cognition” Bolt-on Version of the Japanese EQ-5D-5L (EQ-5D-5L+C) by Adding a Cognitive Dimension for the Elderly

    Dec 1, 2022, 00:00

  • HPR126 Lessons From the US and EU: How China Can Avoid Missteps in Biosimilar Adoption

    Dec 1, 2022, 00:00

  • RWD42 Patient Characteristics and Treatment Patterns in Patients With Persistent, Recurrent, or Metastatic (P/R/M) Cervical Cancer: A Real-World Data Analysis in the US

    Dec 1, 2022, 00:00

  • EE49 Cost-Effectiveness of Relmacabtagene Autoleucel (ANTI-CD19 AUTOLOGOUS CAR-T CELL IMMUNOTHERAPY PRODUCT) Vs Salvage Chemotherapy for Chinese Relapsed or Refractory Large B-Cell Lymphoma Patients

    Dec 1, 2022, 00:00

  • EPH57 Epidemiology of Alopecia Areata Across Global Regions – A Systematic Literature Review

    Dec 1, 2022, 00:00

  • EE446 Cost-Effectiveness of Pneumococcal Vaccination for at-Risk and High-Risk Elderly in Limited Resource Context: Lessons Learned From Thailand

    Dec 1, 2022, 00:00

  • P62 Parametric Survival Extrapolations of Larotrectinib and Entrectinib for NTRK Fusion Cancers

    Dec 1, 2022, 00:00

  • PCR68 Systematic Literature Review of Health State Utility Values in Patients With Huntington's Disease: Evidence From the Europe and United States

    Dec 1, 2022, 00:00

  • MSR47 A Stepwise Approach for Assessing the Feasibility of Population-Adjusted Indirect Treatment Comparisons

    Dec 1, 2022, 00:00

  • RWD71 Is the Real-World Evidence for Effectiveness and Safety of Biosimilars Vis-à-vis Originators FDA Compliant?

    Dec 1, 2022, 00:00

  • EE68 Burden of Hospitalization, Costs and Co-Morbidities in Patients With Chronic Lymphocytic Leukemia: Analysis of Real-World Evidence Using National In-Patient Hospital Database

    Dec 1, 2022, 00:00

  • EPH152 Ten-Year Epidemiology, Economic Burden and All-Cause Mortality Among Palmoplantar Pustolosis Patients: A 10-Year Canadian Prevalence Study of Inpatient Care, Emergency Departments, and Hospital- or Community-Based Outpatient Clinics

    Dec 1, 2022, 00:00

  • HTA66 Price Increases of Prescription Drugs in Sweden – In Which Cases Are They Approved?

    Dec 1, 2022, 00:00

  • HTA42 Use of Health-Related Quality of Life (HRQoL) Outcomes/Patient-Reported Outcomes (PROs) in Rare Hematological Disease (RHD) Health Technology Assessment (HTA) Submissions

    Dec 1, 2022, 00:00

  • CO56 Comparative Effectiveness of Teneligliptin Versus Glimepiride as Add on Medications for Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin

    Dec 1, 2022, 00:00

  • EE557 Cost-Effectiveness of Linaclotide Compared to Osmotic Laxatives in the Treatment of Irritable Bowel Syndrome With Constipation in China

    Dec 1, 2022, 00:00

  • CO120 Evidence Gap Analysis of the Burden of Illness and Treatment of Pemphigus Vulgaris and Foliaceus

    Dec 1, 2022, 00:00

  • MSR71 Performance of AIC and BIC for the Extrapolation of Survival Data With Different Levels of Censoring

    Dec 1, 2022, 00:00

  • Economic Evaluation of Prenatal and Postpartum Care in Women With Gestational Diabetes and Hypertensive Disorders of Pregnancy: A Systematic Review

    Dec 1, 2022, 00:00

  • PCR22 Measurement Properties of 15-Item Singapore Caregiver Quality of Life Scale (SCQOLS-15) in Family Caregivers of Patients With Heart Diseases

    Dec 1, 2022, 00:00

  • EE361 Cost-Effectiveness Analysis of Ribociclib Versus Abemaciclib in the First-Line (1L) Treatment of Postmenopausal Women With HR+/HER2- Advanced Breast Cancer (ABC)

    Dec 1, 2022, 00:00

  • EPH135 A Cross Sectional Survey of Student Pharmacists’ Vaccine Hesitancy Perceptions at a United States College of Pharmacy

    Dec 1, 2022, 00:00

  • EE418 A Budget Impact Analysis of Introducing a New Combination of Atorvastatin and Ezetimibe in Greece

    Dec 1, 2022, 00:00

  • EE162 Cost-Effectiveness of Obinutuzumab Plus Bendamustine and Followed by Obinutuzumab Maintenance Therapy in Chinese Patients With Relapse and Refractory Follicular Lymphoma

    Dec 1, 2022, 00:00

  • An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure

    Dec 1, 2022, 00:00

  • HPR38 A Quantitative Assessment of Reimubursement and Existing Price Levels for Multiple Myeloma Patient Across US, EU, CA Emerging Markets

    Dec 1, 2022, 00:00

  • EE198 Integrating Health Economic Analysis into External Quality Assessment of Laboratory Tests: Evaluating Costs and Consequences of Bias in Lipid Tests in the Prevention of Cardiovascular Disease in Swedish Diabetes Patients

    Dec 1, 2022, 00:00

  • PCR198 Contemporary Trends in the Use of Generic Patient-Reported Outcome Measures in Pediatric Clinical Trials: An Analysis of Clinicaltrials.Gov

    Dec 1, 2022, 00:00

  • EE516 Budget-Impact Model of Adalimumab-Biosimilar Sandoz in the Management of Autoimmune Diseases in the Middle East

    Dec 1, 2022, 00:00

  • PCR194 What Can We Learn From One Million Completed Daily Questionnaires About Patient Compliance and Burden?

    Dec 1, 2022, 00:00

  • EE58 Budget Impact Analysis of Minimally Invasive Techniques Against Abdominal Hysterectomy for Benign Gynaecological Conditions: A Spanish Hospital Perspective

    Dec 1, 2022, 00:00

  • PCR87 Influence of Nutritional State and the Phase Angle in the Health Related Quality of Life and Clinical Outcome in Head and Neck Cancer

    Dec 1, 2022, 00:00

  • EPH95 Costs of Ruling Out Coronary Heart Disease (CHD) in German Outpatient Service

    Dec 1, 2022, 00:00

  • EE63 Economic Burden of Respiratory Syncytial Virus in Adults in the United States

    Dec 1, 2022, 00:00

  • EPH204 What Doesn't Kill You: Re-Evaluating Our Approach to High Burden, Low Mortality Chronic Diseases With a Focus on Migraine and Multiple Sclerosis

    Dec 1, 2022, 00:00

  • RWD79 Burden of Hospitalization, Costs and Comorbidities in Medicaid Patients With Veno-Occlusive Disease (VOD): Analysis of National In-Patient Hospital Database

    Dec 1, 2022, 00:00

  • PCR186 The Life With Cystic Fibrosis: Socioeconomic Impact of the Disease on Patients and Their Caregivers in the Czech Republic

    Dec 1, 2022, 00:00

  • EE566 Cost-Effectiveness and Budget Impact Analysis of Selective Internal Radiation Therapy Versus Atezolizumab Plus Bevacizumab From a German Statutory Health Insurance Perspective

    Dec 1, 2022, 00:00

  • EE163 Analysis of Healthcare Resource Use of the Robotic Surgery System for Rectal Cancer in Japan

    Dec 1, 2022, 00:00

  • PCR253 Establishing Content Validity of Three New Patient Reported Outcome (PRO) Measures for Use in HIV Long-Acting Oral Antiretroviral Therapy (LA-OART) Clinical Trials

    Dec 1, 2022, 00:00

  • P11 Informal Care Costs According to Age and Proximity to Death to Support Cost-Effectiveness Analyses

    Dec 1, 2022, 00:00

  • RWD83 Real-World Treatment Patterns in Chronic Spontaneous Urticaria in the United States

    Dec 1, 2022, 00:00

  • EE592 Long-Term Health and Economic Benefits of Switching to Tenofovir Alafenamide Versus Continuing on Entecavir in Chronic Hepatitis B Patients With Low-Level Viremia in Saudi Arabia

    Dec 1, 2022, 00:00

  • EE386 Impact of Publication of the French Commission for Economic and Public Health Evaluation (CEESP) Doctrine on the Conclusions of Its Economic Opinions

    Dec 1, 2022, 00:00

  • CO168 Adaptive Behaviors Over Time in Children and Young Adults With Classic Galactosemia

    Dec 1, 2022, 00:00

  • RWD74 Real-World Effectiveness of CDK 4/6 Inhibitor as First-Line Treatment in Patients With HR+, HER2- Advanced Breast Cancer in South Korea - Focused on Underrepresented Younger and Older Age

    Dec 1, 2022, 00:00

  • EE501 Making R-Based Economic Models Even Shinier With Web-Based Interfaces

    Dec 1, 2022, 00:00

  • EE41 Healthcare Resource Utilization of Severe, Uncontrolled T2LOW and Non-T2LOW Asthma in Finland During 2018-2021

    Dec 1, 2022, 00:00

  • EE258 A Methodological Foundation for the Creation of the Pharmaceutical RD Call Options Market

    Dec 1, 2022, 00:00
  • «
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29 (current)
  • 30
  • »